|
1
|
Okazaki Y, Furuno M, Kasukawa T, Adachi J,
Bono H, Kondo S, Nikaido I, Osato N, Saito R, Suzuki H, et al:
Analysis of the mouse transcriptome based on functional annotation
of 60,770 full-length cDNAs. Nature. 420:563–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jathar S, Kumar V, Srivastava J and
Tripathi V: Technological developments in lncRNA biology. Adv Exp
Med Biol. 1008:283–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng GX, Do BT, Webster DE, Khavari PA
and Chang HY: Dicer-microRNA-Myc circuit promotes transcription of
hundreds of long noncoding RNAs. Nat Struct Mol Biol. 21:585–590.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Z, Wang X, Cao S, Han X, Wang Z,
Zhao X, Liu X, Li G, Pan X and Lei D: The long noncoding RNA TUG1
promotes laryngeal cancer proliferation and migration. Cell Physiol
Biochem. 49:2511–2520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez Y and Huarte M: Long non-coding
RNAs: Challenges for diagnosis and therapies. Nucleic Acid Ther.
23:15–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Veneziano D, Di Bella S, Nigita G, Laganà
A, Ferro A and Croce CM: Noncoding RNA: Current deep sequencing
data analysis approaches and challenges. Hum Mutat. 37:1283–1298.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Botti G, Marra L, Malzone MG, Anniciello
A, Botti C, Franco R and Cantile M: LncRNA HOTAIR as prognostic
circulating marker and potential therapeutic target in patients
with tumor diseases. Curr Drug Targets. 18:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He Y, Luo Y, Liang B, Ye L, Lu G and He W:
Potential applications of MEG3 in cancer diagnosis and prognosis.
Oncotarget. 8:73282–73295. 2017.PubMed/NCBI
|
|
14
|
Peng Z, Wang J, Shan B, Yuan F, Li B, Dong
Y, Peng W, Shi W, Cheng Y, Gao Y, et al: Genome-wide analyses of
long noncoding RNA expression profiles in lung adenocarcinoma. Sci
Rep. 7:153312017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang W, Zhao Z, Yang F, Wang H, Wu F,
Liang T, Yan X, Li J, Lan Q, Wang J and Zhao J: An immune-related
lncRNA signature for patients with anaplastic gliomas. J
Neurooncol. 136:263–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Russell MR, Penikis A, Oldridge DA,
Alvarez-Dominguez JR, McDaniel L, Diamond M, Padovan O, Raman P, Li
Y, Wei JS, et al: CASC15-S is a tumor suppressor lncRNA at the 6p22
neuroblastoma susceptibility locus. Cancer Res. 75:3155–3166. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin C, Yuan G, Hu Z, Zeng Y, Qiu X, Yu H
and He S: Bioinformatics analysis of the interactions among lncRNA,
miRNA and mRNA expression, genetic mutations and epigenetic
modifications in hepatocellular carcinoma. Mol Med Rep.
19:1356–1364. 2019.PubMed/NCBI
|
|
21
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
22
|
Pan W, Zhou L, Ge M, Zhang B, Yang X,
Xiong X, Fu G, Zhang J, Nie X, Li H, et al: Whole exome sequencing
identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid
carcinoma driver alternations. Hum Mol Genet. 25:1875–1884. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Wu W and Jin J: A novel mutation in
SIRT1-AS leading to a decreased risk of HCC. Oncol Rep.
34:2343–2350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zampetaki A, Albrecht A and Steinhofel K:
Long non-coding RNA structure and function: Is there a link? Front
Physiol. 9:12012018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao RW, Wang Y and Chen LL: Cellular
functions of long noncoding RNAs. Nat Cell Biol. 21:542–551. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu XS, Wang F, Li HF, Hu YP, Jiang L,
Zhang F, Li ML, Wang XA, Jin YP, Zhang YJ, et al: LncRNA-PAGBC acts
as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO
Rep. 18:1837–1853. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Signal B, Gloss BS and Dinger ME:
Computational approaches for functional prediction and
characterisation of long noncoding RNAs. Trends Genet. 32:620–637.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jaksik R, Iwanaszko M, Rzeszowska-Wolny J
and Kimmel M: Microarray experiments and factors which affect their
reliability. Biol Direct. 10:462015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi Y and Shang J: Long noncoding RNA
expression profiling using arraystar LncRNA microarrays. Methods
Mol Biol. 1402:43–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun Y and Ma L: New insights into long
non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel).
11:2019. View Article : Google Scholar
|
|
31
|
Tee AE, Bing L, Song R, Li J, Pasquier E,
Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, et al: The
long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by
up-regulating pro-angiogenic gene expression. Oncotarget.
7:8663–8675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long noncoding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G
and Sun B: LINC00152 promotes proliferation in hepatocellular
carcinoma by targeting EpCAM via the mTOR signaling pathway.
Oncotarget. 6:42813–42824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Li M, Dong C, Ma Y, Xiao L, Zuo S,
Gong Y, Ren T and Sun B: Linc00152 knockdown inactivates the
Akt/mTOR and Notch1 pathways to exert its anti-hemangioma effect.
Life Sci. 223:22–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Xiang C, Wang Y, Duan Y, Liu C,
Jin Y and Zhang Y: lncRNA LINC00152 knockdown had effects to
suppress biological activity of lung cancer via EGFR/PI3K/AKT
pathway. Biomed Pharmacother. 94:644–651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu J, Guo J, Jiang Y, Liu Y, Liao K, Fu Z
and Xiong Z: Improved characterization of the relationship between
long intergenic non-coding RNA Linc00152 and the occurrence and
development of malignancies. Cancer Med. 8:4722–4731. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu Y, Dai B, Zhang H, Shi G, Shen Y and
Ye D: Long non-coding RNA LOC572558 inhibits bladder cancer cell
proliferation and tumor growth by regulating the AKT-MDM2-p53
signaling axis. Cancer Lett. 380:369–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Podnar J, Deiderick H, Huerta G and
Hunicke-Smith S: Next-generation sequencing RNA-Seq library
construction. Curr Protoc Mol Biol. 106:4.21.1–19. 2014. View Article : Google Scholar
|
|
39
|
Metzker ML: Sequencing technologies-the
next generation. Nat Rev Genet. 11:31–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin T, Hou PF, Meng S, Chen F, Jiang T, Li
ML, Shi ML, Liu JJ, Zheng JN and Bai J: Emerging roles of p53
related lncRNAs in cancer progression: A systematic review. Int J
Biol Sci. 15:1287–1298. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sánchez Y, Segura V, Marín-Béjar O, Athie
A, Marchese FP, González J, Bujanda L, Guo S, Matheu A and Huarte
M: Genome-wide analysis of the human p53 transcriptional network
unveils a lncRNA tumour suppressor signature. Nat Commun.
5:58122014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hünten S, Kaller M, Drepper F, Oeljeklaus
S, Bonfert T, Erhard F, Dueck A, Eichner N, Friedel CC, Meister G,
et al: p53-regulated networks of protein, mRNA, miRNA and lncRNA
expression revealed by integrated pulsed stable isotope labeling
with amino acids in cell culture (pSILAC) and next generation
sequencing (NGS) analyses. Mol Cell Proteomics. 14:2609–2629. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kaller M, Götz U and Hermeking H: Loss of
p53-inducible long non-coding RNA LINC01021 increases
chemosensitivity. Oncotarget. 8:102783–102800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yamaguchi H and Hung MC: Regulation and
role of EZH2 in cancer. Cancer Res Treat. 46:209–222. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Michalak EM, Burr ML, Bannister AJ and
Dawson MA: The roles of DNA, RNA and histone methylation in ageing
and cancer. Nat Rev Mol Cell Biol. 20:573–589. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Merry CR, Forrest ME, Sabers JN, Beard L,
Gao XH, Hatzoglou M, Jackson MW, Wang Z, Markowitz SD and Khalil
AM: DNMT1-associated long non-coding RNAs regulate global gene
expression and DNA methylation in colon cancer. Hum Mol Genet.
24:6240–6253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Somasundaram S, Forrest ME, Moinova H,
Cohen A, Varadan V, LaFramboise T, Markowitz S and Khalil AM: The
DNMT1-associated lincRNA DACOR1 reprograms genome-wide DNA
methylation in colon cancer. Clin Epigenetics. 10:1272018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kondo A, Nonaka A, Shimamura T, Yamamoto
S, Yoshida T, Kodama T, Aburatani H and Osawa T: Long noncoding RNA
JHDM1D-AS1 promotes tumor growth by regulating angiogenesis in
response to nutrient starvation. Mol Cell Biol. 37:2017. View Article : Google Scholar
|
|
50
|
Hu Q, Ye Y, Chan LC, Li Y, Liang K, Lin A,
Egranov SD, Zhang Y, Xia W, Gong J, et al: Oncogenic lncRNA
downregulates cancer cell antigen presentation and intrinsic tumor
suppression. Nat Immunol. 20:835–851. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Matsui M and Corey DR: Non-coding RNAs as
drug targets. Nat Rev Drug Discov. 16:167–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
de Kok JB, Verhaegh GW, Roelofs RW,
Hessels D, Kiemeney LA, Aalders TW, Swinkels DW and Schalken JA:
DD3(PCA3), a very sensitive and specific marker to detect prostate
tumors. Cancer Res. 62:2695–2698. 2002.PubMed/NCBI
|
|
54
|
Prensner JR, Zhao S, Erho N, Schipper M,
Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A,
Siddiqui J, et al: RNA biomarkers associated with metastatic
progression in prostate cancer: A multi-institutional
high-throughput analysis of SChLAP1. Lancet Oncol. 15:1469–1480.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Smolle MA, Bauernhofer T, Pummer K, Calin
GA and Pichler M: Current insights into long non-coding RNAs
(LncRNAs) in prostate cancer. Int J Mol Sci. 18:2017. View Article : Google Scholar
|
|
56
|
Merry CR, Mcmahon S, Thompson CL, Miskimen
KL, Harris LN and Khalil AM: Integrative transcriptome-wide
analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+
breast cancer. Breast Cancer Res Treat. 150:321–334. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li W, Zhai L, Wang H, Liu C, Zhang J, Chen
W and Wei Q: Downregulation of LncRNA GAS5 causes trastuzumab
resistance in breast cancer. Oncotarget. 7:27778–27786.
2016.PubMed/NCBI
|
|
58
|
Fradet V, Toren P, Nguile-Makao M, Lodde
M, Lévesque J, Léger C, Caron A, Bergeron A, Ben-Zvi T, Lacombe L,
et al: Prognostic value of urinary prostate cancer antigen 3 (PCA3)
during active surveillance of patients with low-risk prostate
cancer receiving 5α-reductase inhibitors. BJU Int. 121:399–404.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ma W, Chen X, Ding L, Ma J, Jing W, Lan T,
Sattar H, Wei Y, Zhou F and Yuan Y: The prognostic value of long
noncoding RNAs in prostate cancer: A systematic review and
meta-analysis. Oncotarget. 8:57755–57765. 2017.PubMed/NCBI
|
|
60
|
Liu L, Meng T, Yang XH, Sayim P, Lei C,
Jin B, Ge L and Wang HJ: Prognostic and predictive value of long
non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their
effects on colorectal cancer cell proliferation, migration and
invasion. Cancer Biomark. 22:283–299. 2018. View Article : Google Scholar : PubMed/NCBI
|
